Meanwhile, the expression levels of CCL5, CD14, CD53, and CD63 in CD54+ tsNeus were increased from the time point of 3 days to 10 days in mice bearing subcutaneous GC (Fig. 2L). The gene discussed is CD53; the disease is gastric cancer.